Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
29 November
Header
Header image
Highlight of the week

News

Industry, researchers and patients warn of the importance of Upholding Competitive Clinical Trial Authorisation Timelines Ahead of Trialogue Agreement
27 November 2013

  27 November, Brussels – Clinical trials are conducted globally and there is increasing international competition in this area because clinical research creates jobs, drives academic [...] Read more

News

News

EFPIA welcomes the Commission's Proposal on the protection of undisclosed know-how and business information ("Trade Secrets")
28 November 2013

The creation of proprietary know-how and business information are woven into the fabric of the pharmaceutical industry. Almost every aspect of the drug development process involves the [...] Read more

From our blog

From our blog

World COPD Day: Calling for Investment in Research to Reduce the Burden
28 November 2013 by Richard Bergström

November 28 marks World COPD Day, which aims to raise awareness around Chronic Obstructive Pulmonary Disease. A long-term disease of the lungs and airways, COPD [...] Read more

Documents

From our blog

EFPIA position on Clinical Trials Regulation trialogue
27 November 2013 (Position Papers)

As the revision of the Clinical Trial Directive enters the Trialogue phase, it is critical to remember that the key objective of this legislation process [...] Read more

What we are reading

What we are reading

The Impact of Vaccines
29 November 2013

A recent study published in The New England Journal of Medicine shows that vaccination programmes for kids have prevented more than 100 million cases of serious contagious disease since 1924 -- and that's just in the US. This NYT blog examines the stats and the big data analysis that generated them.

Read more

What we are reading

Speak Up About Fake Medicines
29 November 2013

"Speak up about fake medicines" is the tagline for Fight the Fakes, a campaign against fake medicines that brings together ten global health organisations to protect patients from counterfeiting. Read the IFPMA press release announcing the campaign launch. 

Read more

What we are reading

Feedback Following the Lithuanian Health Forum
29 November 2013

Two blogs in BMJ Open take a closer look at the recent event "Sustainable Health Systems for Inclusive Growth in Europe", held in Vilnius November 19-20. Read more, here and here.

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail